NIOSH Conformity Assessment Letter to Manufacturers, CA 2021-1032 - Effective Immediately – In response to COVID-19 – Updated NIOSH fraud and fraudulent statements policy and prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing domestic and non-domestic approval holders, new domestic manufacturers/applicants, and new non-domestic manufacturers/applicants. Supersedes NIOSH CA 2020-1031. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notices: CA-2022-1041 and CA-2022-1040.

Details

• Description:
  NIOSH issued an earlier version of this Conformity Assessment Letter to Manufacturers (CA 2020-1031) in August 2020 to address the overwhelming number of new applications submitted to the NIOSH Respirator Approval Program as well as the serious and ongoing attempts to defraud the Program. The February 2021 version of this Letter provides new guidance on fraud and fraudulent statements. The February 2021 version of this Letter also updates the prioritization order for accepting and examining particulate filtering respirator approval applications and clarifies NIOSH’s definitions of “domestic manufacturer” and “non-domestic manufacturer.”
• Document Type:
  Report
• CIO:
  NIOSH
• Division:
  NIOSH_NPPTL
• NIOSHTIC Number:
  nn:na
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:235b883fe758f8bc2980b75eb3cf276a305e6991b48730685da47004298d2e51f0688939ca3ac3fd7b17a749e6756cb6767af7403fda23bacb16ff18cf10d5e2
• Download URL:
  https://stacks.cdc.gov/view/cdc/137554/cdc_137554_DS1.pdf
• File Type:
  [PDF - 193.04 KB ]